Clinical Trial Update: Study of Cadonilimab (AK104) Plus Lenvatinib in Patients With Advanced Endometrial Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating cadonilimab (AK104) in combination with lenvatinib for advanced endometrial cancer; the study is currently active but not recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Adenocarcinoma
• Endometrial Cancer

Drugs mentioned

• Cadonilimab (AK104) (Cadonilimab)
• Lenvatinib (lenvatinib)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Endometrial Cancer, Endometrial Adenocarcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING